These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35467175)

  • 1. Vaccination or NPI? A conjoint analysis of German citizens' preferences in the context of the COVID-19 pandemic.
    Bughin J; Cincera M; Kiepfer E; Reykowska D; Philippi F; Żyszkiewicz M; Ohme R; Frank D
    Eur J Health Econ; 2023 Feb; 24(1):39-52. PubMed ID: 35467175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.
    Wang Y; Luangasanatip N; Pan-Ngum W; Isaranuwatchai W; Prawjaeng J; Saralamba S; Painter C; Briones JR; Teerawattananon Y
    Eur J Health Econ; 2023 Jul; 24(5):735-748. PubMed ID: 35951243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When to be vaccinated? What to consider? Modelling decision-making and time preference for COVID-19 vaccine through a conjoint experiment.
    Yue PHR; Lau HPB; Ng SM; Chan LWC; Yuen S
    Vaccine; 2023 Oct; 41(42):6300-6308. PubMed ID: 37679277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.
    Kelso JK; Halder N; Milne GJ
    BMC Infect Dis; 2013 Feb; 13():81. PubMed ID: 23398722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of Preferences for COVID-19 Vaccines in Hungary Based on Their Properties-Examining the Impact of Pandemic Awareness with a Hybrid Choice Approach.
    Blaga Z; Czine P; Takacs B; Szilagyi A; Szekeres R; Wachal Z; Hegedus C; Buchholcz G; Varga B; Priksz D; Bombicz M; Szabo AM; Kiss R; Gesztelyi R; Romanescu DD; Szabo Z; Szucs M; Balogh P; Szilvassy Z; Juhasz B
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.
    Patterson BJ; Myers K; Stewart A; Mange B; Hillson EM; Poulos C
    Expert Rev Vaccines; 2021 Jun; 20(6):729-741. PubMed ID: 33902368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands.
    Mouter N; Boxebeld S; Kessels R; van Wijhe M; de Wit A; Lambooij M; van Exel J
    Value Health; 2022 Aug; 25(8):1290-1297. PubMed ID: 35527162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
    Milne GJ; Carrivick J; Whyatt D
    BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccine hesitancy and vaccine passports: a cross-sectional conjoint experiment in Japan.
    Okamoto S; Kamimura K; Komamura K
    BMJ Open; 2022 Jun; 12(6):e060829. PubMed ID: 35710243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine alliance building blocks: a conjoint experiment on popular support for international COVID-19 cooperation formats.
    Vanhuysse P; Jankowski M; Tepe M
    Policy Sci; 2021; 54(3):493-506. PubMed ID: 34393278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine nationalism among the public: A cross-country experimental evidence of own-country bias towards COVID-19 vaccination.
    Barceló J; Sheen GC; Tung HH; Wu WC
    Soc Sci Med; 2022 Oct; 310():115278. PubMed ID: 35994879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Please, you go first!" preferences for a COVID-19 vaccine among adults in the Netherlands.
    Mouter N; de Ruijter A; Ardine de Wit G; Lambooij MS; van Wijhe M; van Exel J; Kessels R
    Soc Sci Med; 2022 Jan; 292():114626. PubMed ID: 34883311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization funding across 28 European countries.
    Faivre P; Benčina G; Campbell R; Quilici S; Dauby N; Tešović G; Bonanni P; Drury R
    Expert Rev Vaccines; 2021 Jun; 20(6):639-647. PubMed ID: 33759675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can a COVID-19 vaccine live up to Americans' expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions.
    Motta M
    Soc Sci Med; 2021 Mar; 272():113642. PubMed ID: 33414031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories.
    Ge Y; Zhang WB; Wu X; Ruktanonchai CW; Liu H; Wang J; Song Y; Liu M; Yan W; Yang J; Cleary E; Qader SH; Atuhaire F; Ruktanonchai NW; Tatem AJ; Lai S
    Nat Commun; 2022 Jun; 13(1):3106. PubMed ID: 35661759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences for public engagement in decision-making regarding four COVID-19 non-pharmaceutical interventions in the Netherlands: A survey study.
    Kemper S; Bongers M; Kupper F; De Vries M; Timen A
    PLoS One; 2023; 18(10):e0292119. PubMed ID: 37796885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.
    Halder N; Kelso JK; Milne GJ
    BMC Infect Dis; 2014 May; 14():266. PubMed ID: 24884470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis.
    Igarashi A; Nakano Y; Yoneyama-Hirozane M
    Expert Rev Vaccines; 2022 Feb; 21(2):241-248. PubMed ID: 35073824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.